by admin_63069 | Oct 12, 2021 | Related Topics
Expert Marc A. Bjurlin, DO, MSc, FACOS, presents his view
by admin_63069 | Oct 8, 2021 | Related Topics
CURE spoke with a cancer rights attorney about what financial toxicity is and ways to address this burden before assistance is needed.
by admin_63069 | Oct 5, 2021 | Related Topics
Study findings suggest early initiation may not “meaningfully” improve survival outcomes
by admin_63069 | Oct 1, 2021 | Related Topics
Stereotactic body radiotherapy, a form of external beam radiation therapy that uses a higher dose of radiation, had a 4-year cure rate of 82%.
by admin_63069 | Sep 28, 2021 | Related Topics
Benefits, eligibility, results and more
by admin_63069 | Sep 24, 2021 | Related Topics
NCCN has expanded germline testing in metastatic prostate cancer to all patients with high-risk, very high-risk, or regional prostate cancer.
